Latest News
ISTB delivers higher yields and stronger 3-year growth, while VTES offers tax-exempt municipal exposure with a lower expense ratio. Which suits your portfolio?
Via The Motley Fool · July 6, 2026
Joby's valuation is getting another big lift in Monday's trading.
Via The Motley Fool · July 6, 2026
Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.
Via MarketBeat · July 6, 2026
IVV's 0.03% expense ratio and $886 billion in assets make it a compelling alternative for buy-and-hold investors seeking broad market exposure.
Via The Motley Fool · July 6, 2026
An elevated valuation coupled with massive revenue growth makes the stock's direction more uncertain.
Via The Motley Fool · July 6, 2026
The stock hasn't been trading this low since 2018.
Via The Motley Fool · July 6, 2026
Success in the EV market isn't guaranteed, but Rivian's recent moves appear to be the right ones.
Via The Motley Fool · July 6, 2026
Home Depot dominates the pro market, while Lowe's continues to enjoy strong perception among homeowners.
Via The Motley Fool · July 6, 2026
Marvell is evolving from a legacy chipmaker into a high-growth AI play.
Via The Motley Fool · July 6, 2026
KBR plans to spin off its two segments this year as insider buying and analyst price targets suggest the stock trades at a deep discount with significant upside potential.
Via MarketBeat · July 6, 2026
iShares silver miners ETF offers lower costs and higher dividend yield, but carries more volatility than Sprott's gold-focused alternative.
Via The Motley Fool · July 6, 2026
Meta wants to become more like its hyperscaler peers.
Via The Motley Fool · July 6, 2026
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Via The Motley Fool · July 6, 2026
RZG delivered stronger 1-year returns at 39.70%, but IJT's lower 0.18% expense ratio and $8.3B in assets offer cost advantages for long-term investors.
Via The Motley Fool · July 6, 2026
Defense spending is surging while airline profits are under pressure. The choice between these two funds comes down to which story you believe in more.
Via The Motley Fool · July 6, 2026
These two retail stocks have generated nearly identical returns over the past five years.
Via The Motley Fool · July 6, 2026
Small caps just had their best first half since 1991.
Via The Motley Fool · July 6, 2026
Choosing the right sport to focus on can significantly improve your overall experience on sports platforms in 2026. While many users explore multiple sport
Via Talk Markets · July 6, 2026
Starbucks Corp (NASDAQ: SBUX) shares are trading lower Monday, despite a lack of company-specific news for the session.
Via Benzinga · July 6, 2026
SK Hynix is scheduled to be listed on the Nasdaq on Friday, July 10.
Via The Motley Fool · July 6, 2026
Bitmine stock is climbing after the company reported total crypto holdings, cash and marketable securities of $11.1 billion.
Via Benzinga · July 6, 2026
The FAA granted a waiver for drone protection of World Cup stadiums.
Via Investor's Business Daily · July 6, 2026
Pfizer was downgraded to Hold as analysts cited delayed pipeline catalysts, management changes and reduced near-term re-rating potential.
Via Benzinga · July 6, 2026
Bitcoin rebounded above $63,000 over the weekend, with positive spot ETF inflows helping offset concerns surrounding Strategy's reported $215 million Bitcoin sale. Analyst Ali Martinez flagged a short-term TD Sequential sell signal on BTC.
Via Benzinga · July 6, 2026
HSBC upgrades Gilead Sciences (GILD) to Buy, raising its price target to $155 on strong long-acting HIV & oncology potential.
Via Benzinga · July 6, 2026